Billings Clinic
Especially For:

Clinical Trials

Title   Brain Cancer (N057K): Newly Dx Glioblastoma
Description   Adjuvant Temozolomide and Everlimus in Newly Diagnosed Glioblastoma
IRB Number   NCCTG N057K
Category   Brain
Inclusion/Notes   High Grade
Status   TEMPORARILY CLOSED
Start Date   03/12/2010
Principal Investigator (PI)   John Schallenkamp, MD
Contact Name   Judy Miller
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.